Chemical Structure (Concerta 01)
Concerta Tablet, Extended Release
Product Images NDC 50458-587
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Concerta (NDC 50458-587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Concerta 02)
This is a graph showing the mean plasma concentration of methylphenidate in ng/mL over a 30 hour time period after administration of Concerta (18 mg capsules) and immediate-release methylphenidate (5 mg tablets). The x-axis represents time in hours and the y-axis represents the plasma concentration in ng/mL.*
Figure 2 (Concerta 03)
Figure 3 (Concerta 04)
This appears to be a graph or chart showing the effects of Concerta once a day (20 mg) on "Kifenuve" over a period of time. The x-axis shows the hours post-initial dose, ranging from 1 to 12. The y-axis is not labeled, so it's unclear what unit of measure is being used. There are 2 sets of data, likely representing different groups or individuals, with corresponding lines and symbols in different colors. However, without a legend or additional information, it's not possible to provide more details or draw meaningful conclusions from this data.*
Principal Display Panel (18 mg Tablet Bottle Label)
This is a description of a medication called CONCERTA, which is distributed by Janssen Pharmaceuticals. It contains 18 mg of methylphenidate hydrochloride in a controlled-release formulation and is available in 100-tablet bottles. The medication is intended for prescription use only and requires a medication guide to be provided by your pharmacist. The packaging also contains dosage information. The GTIN is 00350458585018 and NDC is 50458-585-01.*
Principal Display Panel (27 mg Tablet Bottle Label)
This is a description of a medication called Concerta, with a GTIN of 00350458588019 and an NDC of 50458-588-01, distributed by Janssen Pharmaceuticals. The medication is an extended-release tablet containing 27 mg of methylphenidate hydrochloride, intended for prescription use only. The medication guide provided by the pharmacist should be consulted for dosage information. The package contains 100 tablets. The remaining text is not relevant or recognizable.*
Principal Display Panel (36 mg Tablet Bottle Label)
Principal Display Panel (54 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
